[Asia Economy Reporter Myunghwan Lee] Samsung Biologics announced on the 4th that it has signed a pharmaceutical contract manufacturing agreement worth 276.82938 billion KRW with MSD International Business.
The contract amount corresponds to 17.65% of last year's sales. The contract date is July 2, and the contract period is from July 1 to December 31, 2028.
Samsung Biologics added, "The contract amount may increase to 381.86 million USD depending on the customer's demand increase."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
